#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Advanced systemic mastocytosis Immunodeficiency common variable Small intestine leiomyosarcoma Sarcoma Pseudomyxoma peritonei Noonan syndrome Glioma Retinopathy proliferative Corneal neovascularisation Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Cystic fibrosis lung Mantle cell lymphoma refractory Oesophageal adenocarcinoma stage II Anal cancer More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma Mantle cell lymphoma refractory – Life with Disease Loeys-Dietz syndrome – Diagnostics Hereditary ataxia – Treatment Haemophilia A with anti factor VIII Mucopolysaccharidosis III – Basic Information Richter’s syndrome – Treatment Marfan’s syndrome – Diagnostics Lysosomal storage disorder – Treatment Osteosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbd1016 VANDETANIB Mesna Clonidine Hydrochloride Immunoglobulin A Cd19-Car_Lenti_Allo Prednisolone Sodium Succinate Hydrocortisone SODIUM SULFIDE NONAHYDRATE 99MTC-EUK-(SO3)CY5-MAS3 Dabigatran Oxazepam Sulfamethizole TALADEGIB Timothy Grass Pollen Extract Dl-Alpha Tocopherol Acetate Ciclosporin Phentermine Procarbazine Mosliciguat More therapies…

    Learn about Your Condition

    Medication overuse headache Mitral valve incompetence Myotonic dystrophy Hyperphagia End stage renal disease Synovitis Pre-eclampsia Cutaneous calcification Eye pain Retinoblastoma Acute cardiac event Coronary artery dissection Bladder cancer Head and neck cancer stage III Bipolar I disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DNL952 in Adults with Late‑Onset Pompe Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Germany The Netherlands

  • Tranexamic Acid versus Placebo for Reducing Infection after Mid‑and Hind‑Foot Arthrodesis in Adults with Deformity or Osteoarthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Finland

  • Lidocaine Hydrochloride, Sodium Chloride, and Betamethasone Injections for Adults with Adhesive Capsulitis: A Pilot Efficacy Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Periarthritis
    Investigated Drugs:
    • Betamethasone Dipropionate
    • Lidocaine Hydrochloride
    • Sodium Chloride
    France

  • Metformin hydrochloride plus drug combination to reduce pain, inflammation and biological aging in patients with knee osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Dolutegravir
    • Colchicine
    • Baricitinib
    The Netherlands

  • Zoledronic acid versus placebo for pain relief in children with chronic recurrent multifocal osteomyelitis resistant to NSAIDs

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Osteomyelitis
    Investigated Drugs:
    • Zoledronic Acid
    France

  • Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Intravenous sgt-003 in Ambulatory Male Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • SGT-003
    Belgium France Germany Italy The Netherlands Spain
Previous Page
1 … 29 30 31 32 33 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!